| Miss Jazelle Ann Manalo, | |
|
500 E Esplanade Dr Ste 600, Oxnard, CA 93036-0525 | |
| (805) 981-2883 | |
| (877) 306-6792 |
| Full Name | Miss Jazelle Ann Manalo |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 500 E Esplanade Dr Ste 600, Oxnard, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063115921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 728318 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Jazelle Ann Manalo, 500 E Esplanade Dr Ste 600, Oxnard, CA 93036-0525 Ph: (805) 981-2883 | Miss Jazelle Ann Manalo, 500 E Esplanade Dr Ste 600, Oxnard, CA 93036-0525 Ph: (805) 981-2883 |
News Archive
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
The National Organization for Rare Disorders and other leading disease and disabilities advocacy groups have filed an amicus brief urging the courts to protect Americans from lawsuits that would undermine protections provided by the nation's new health care reform legislation.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.
Stem cells hold great potential for addressing a variety of conditions from spinal cord injuries to cancer, but they can be difficult to control. Scientists are now reporting in the journal ACS Nano a new way to mimic the body's natural approach to programming these cells.
Vernakalant, a new drug for treating recent-onset atrial fibrillation, has proved to be considerably more effective than Ibutilide, an established drug in this indication. It was able to normalize patients' heart rhythm more rapidly and with fewer side-effects ocurring. This was revealed by a study conducted at the Department of Emergency Medicine at Medical University of Vienna/General Hospital that has recently been published in "Europace", a journal of the European Society of Cardiology.
› Verified 2 days ago
Rebecca Ann Daly, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2150 North Victoria Ave, Oxnard, CA 93036 Phone: 805-382-6296 | |
Eva L. Cuevas, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1911 Williams Dr Ste 200, Oxnard, CA 93036 Phone: 805-981-1422 Fax: 805-981-1366 | |
Ms. Luz Elena Diaz-villegas, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2064 Greely Ct, Oxnard, CA 93033 Phone: 805-816-2767 | |
Leslie Evette Arceo, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 W Vineyard Ave, Oxnard, CA 93036 Phone: 805-775-7345 | |
Linda Sue Boyd, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2055 Saviers Rd # 10, Oxnard, CA 93033 Phone: 805-483-2253 | |
Mara Andrea Sibucao, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 4201 Justin Way, Oxnard, CA 93033 Phone: 808-389-7707 |